Aligos Therapeutics, Inc. 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-092614
- Form type
- 10-K
- CIK
- 0001799448
- Primary document
- https://www.sec.gov/Archives/edgar/data/1799448/000119312526092614/algs-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aligos Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.2M | - | - |
| Operating Income | $-88.0M | - | - |
| Net Income | $-24.2M | - | - |
| Eps Basic | -2.45 | - | - |
| Eps Diluted | -2.45 | - | - |
| Cash And Equivalents | $18.3M | - | - |
| Total Assets | $88.5M | - | - |
| Total Liabilities | $35.0M | - | - |
| Shareholders Equity | $53.5M | - | - |
| Operating Cash Flow | $-82.5M | - | - |